1. Home
  2. BDSX vs BHAT Comparison

BDSX vs BHAT Comparison

Compare BDSX & BHAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BDSX
  • BHAT
  • Stock Information
  • Founded
  • BDSX 2005
  • BHAT 2010
  • Country
  • BDSX United States
  • BHAT China
  • Employees
  • BDSX N/A
  • BHAT N/A
  • Industry
  • BDSX Precision Instruments
  • BHAT Recreational Games/Products/Toys
  • Sector
  • BDSX Health Care
  • BHAT Consumer Discretionary
  • Exchange
  • BDSX Nasdaq
  • BHAT Nasdaq
  • Market Cap
  • BDSX 53.0M
  • BHAT 59.1M
  • IPO Year
  • BDSX 2020
  • BHAT 2019
  • Fundamental
  • Price
  • BDSX $7.19
  • BHAT $1.28
  • Analyst Decision
  • BDSX Strong Buy
  • BHAT
  • Analyst Count
  • BDSX 5
  • BHAT 0
  • Target Price
  • BDSX $32.50
  • BHAT N/A
  • AVG Volume (30 Days)
  • BDSX 322.6K
  • BHAT 58.7K
  • Earning Date
  • BDSX 11-03-2025
  • BHAT 12-22-2025
  • Dividend Yield
  • BDSX N/A
  • BHAT N/A
  • EPS Growth
  • BDSX N/A
  • BHAT N/A
  • EPS
  • BDSX N/A
  • BHAT N/A
  • Revenue
  • BDSX $80,173,000.00
  • BHAT $18,724,190.00
  • Revenue This Year
  • BDSX $19.04
  • BHAT N/A
  • Revenue Next Year
  • BDSX $26.39
  • BHAT N/A
  • P/E Ratio
  • BDSX N/A
  • BHAT N/A
  • Revenue Growth
  • BDSX 22.29
  • BHAT N/A
  • 52 Week Low
  • BDSX $3.44
  • BHAT $1.25
  • 52 Week High
  • BDSX $32.20
  • BHAT $24.50
  • Technical
  • Relative Strength Index (RSI)
  • BDSX 49.20
  • BHAT 27.09
  • Support Level
  • BDSX $7.42
  • BHAT $1.25
  • Resistance Level
  • BDSX $8.52
  • BHAT $1.57
  • Average True Range (ATR)
  • BDSX 0.85
  • BHAT 0.07
  • MACD
  • BDSX -0.05
  • BHAT -0.02
  • Stochastic Oscillator
  • BDSX 37.11
  • BHAT 12.12

About BDSX Biodesix Inc.

Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Covid tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.

About BHAT Blue Hat Interactive Entertainment Technology

Blue Hat Interactive Entertainment Technology is focused on commodity trading, including chemicals, jewelry, and precious metals such as gold. It operates a gold and diamond trading and supply chain business. Its business model encompasses physical gold trading, diamond trading, gold derivatives trading, and the development of AI-enabled trading platforms. Its segments include Diamond trading, Commodity trading, Information service, Interactive toys - animation series, and Interactive toys - game series. It derives revenue from Diamond trading. The majority of its revenues are generated in PRC.

Share on Social Networks: